Meta-Analysis: Outcomes in Patients with Suspected Pulmonary Embolism Managed with Computed Tomographic Pulmonary Angiography

  1. Lisa K. Moores, MD;
  2. William L. Jackson, Jr., MD;
  3. Andrew F. Shorr, MD, MPH; and
  4. Jeffrey L. Jackson, MD, MPH
  1. From Walter Reed Army Medical Center, Washington, DC, and the Uniformed Services University of the Health Sciences, Bethesda, Maryland.
    1. Figure 1. CTPA = computed tomographic pulmonary angiography; PE = pulmonary embolism.
      View larger version:
      Figure 1. CTPA = computed tomographic pulmonary angiography; PE = pulmonary embolism. Flow diagram of study selection.
    2. Figure 2. The number of patients for each study is the number of patients eligible for outcome assessment, and the event rates are a combination of recurrent VTE and fatal PE (see ). Values in parentheses on the right-hand side of the figure are the upper bound of the CI unless otherwise indicated.
      View larger version:
      Figure 2. The number of patients for each study is the number of patients eligible for outcome assessment, and the event rates are a combination of recurrent VTE and fatal PE (see ). Values in parentheses on the right-hand side of the figure are the upper bound of the CI unless otherwise indicated. Forest plots of total venous thromboembolism (VTE) events (top) and fatal pulmonary embolism (PE) events (bottom).Table

    Responses to this article

    « Previous | Next Article »Table of Contents